title: [Polychemotherapy of non-small cell bronchial cancer with mitomycin C, ifosfamide and vindesine].
abstract: The results of antineoplastic polychemotherapy in non-small-cell carcinomas of the lungs revealed on overall remission rate of 42.1%, with a distribution from limited to extensive disease of approximately 32% to 58%. Severe undesired side effects of the treatment were not observed, the duration of remission was, on average, 78 days, and the survival period 101 days.
authors.affiliation: Klinik Seltersberg, Giessen der LVA-Hessen.
authors.forename: R
authors.initials: R
authors.lastname: Laumen
authors.forename: H
authors.initials: H
authors.lastname: Jungbluth
authors.forename: J
authors.initials: J
authors.lastname: von Pawel
authors.forename: K
authors.initials: K
authors.lastname: Häussinger
authors.forename: M
authors.initials: M
authors.lastname: Otto
authors.forename: H
authors.initials: H
authors.lastname: Krieger
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D004334:Drug Administration Schedule; D005500:Follow-Up Studies; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage; D008175:Lung Neoplasms / Q000188:drug therapy*; D016685:Mitomycin; D008937:Mitomycins / Q000008:administration & dosage; D014751:Vindesine / Q000008:administration & dosage
chemical_list: D008937:Mitomycins; D016685:Mitomycin; D014751:Vindesine; D007069:Ifosfamide
vernacular_title: Polychemotherapie beim nicht kleinzelligen Bronchialkarzinom mit Mitomycin C, Ifosfamid und Vindesine.